Correlation Between MW Investment and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MW Investment and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MW Investment and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MW Investment Holding and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on MW Investment and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MW Investment with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MW Investment and Lipella Pharmaceuticals.
Diversification Opportunities for MW Investment and Lipella Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between MEGH and Lipella is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MW Investment Holding and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and MW Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MW Investment Holding are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of MW Investment i.e., MW Investment and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between MW Investment and Lipella Pharmaceuticals
Given the investment horizon of 90 days MW Investment Holding is expected to generate 5.27 times more return on investment than Lipella Pharmaceuticals. However, MW Investment is 5.27 times more volatile than Lipella Pharmaceuticals Common. It trades about 0.03 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about -0.01 per unit of risk. If you would invest 0.26 in MW Investment Holding on October 9, 2024 and sell it today you would lose (0.24) from holding MW Investment Holding or give up 92.31% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
MW Investment Holding vs. Lipella Pharmaceuticals Common
Performance |
Timeline |
MW Investment Holding |
Lipella Pharmaceuticals |
MW Investment and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MW Investment and Lipella Pharmaceuticals
The main advantage of trading using opposite MW Investment and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MW Investment position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.MW Investment vs. Corning Incorporated | MW Investment vs. Summit Environmental | MW Investment vs. Bill Com Holdings | MW Investment vs. Gfl Environmental Holdings |
Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |